Aiko Okada

627 total citations
9 papers, 511 citations indexed

About

Aiko Okada is a scholar working on Rheumatology, Immunology and Allergy and Oncology. According to data from OpenAlex, Aiko Okada has authored 9 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 5 papers in Immunology and Allergy and 3 papers in Oncology. Recurrent topics in Aiko Okada's work include Osteoarthritis Treatment and Mechanisms (6 papers), Cell Adhesion Molecules Research (5 papers) and HER2/EGFR in Cancer Research (2 papers). Aiko Okada is often cited by papers focused on Osteoarthritis Treatment and Mechanisms (6 papers), Cell Adhesion Molecules Research (5 papers) and HER2/EGFR in Cancer Research (2 papers). Aiko Okada collaborates with scholars based in Japan and United States. Aiko Okada's co-authors include Yasunori Okada, Taku Yatabe, Takehiro Kimura, Takayuki Shiomi, Miyuki Chijiiwa, Satsuki Mochizuki, Hideo Matsumoto, Yoshinari Fujita, Eiji Ikeda and Yasunori Fujita and has published in prestigious journals such as PLoS ONE, FEBS Letters and American Journal Of Pathology.

In The Last Decade

Aiko Okada

9 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aiko Okada Japan	8	232	182	134	109	107	9	511
Koichiro Komiya Japan	6	232 1.0×	146 0.8×	89 0.7×	56 0.5×	67 0.6×	10	394
Kazunari Fushimi Japan	14	150 0.6×	109 0.6×	173 1.3×	85 0.8×	64 0.6×	30	571
Yoshinari Fujita Japan	7	132 0.6×	91 0.5×	80 0.6×	68 0.6×	68 0.6×	10	292
S.H. Madsen Denmark	8	237 1.0×	105 0.6×	87 0.6×	60 0.6×	59 0.6×	11	388
Kali Chrysovergis United States	8	196 0.8×	244 1.3×	175 1.3×	119 1.1×	36 0.3×	8	550
Brian Wu Canada	7	231 1.0×	207 1.1×	93 0.7×	57 0.5×	26 0.2×	9	495
N. Ogata Japan	5	444 1.9×	199 1.1×	106 0.8×	67 0.6×	44 0.4×	7	628
Yoko Hosaka Japan	9	342 1.5×	221 1.2×	147 1.1×	65 0.6×	43 0.4×	15	549
Valerie A. Siclari United States	9	102 0.4×	341 1.9×	120 0.9×	281 2.6×	33 0.3×	10	658
Mei Zhu United States	5	568 2.4×	480 2.6×	108 0.8×	123 1.1×	77 0.7×	7	819

Countries citing papers authored by Aiko Okada

Since Specialization

Citations

This map shows the geographic impact of Aiko Okada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aiko Okada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aiko Okada more than expected).

Fields of papers citing papers by Aiko Okada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aiko Okada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aiko Okada. The network helps show where Aiko Okada may publish in the future.

Co-authorship network of co-authors of Aiko Okada

This figure shows the co-authorship network connecting the top 25 collaborators of Aiko Okada. A scholar is included among the top collaborators of Aiko Okada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aiko Okada. Aiko Okada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Tani, Joji, Teppei Sakamoto, Aiko Okada, et al.. (2021). Efforts to identify HCV antibody-positive patients in a medium-sized hospital by "Team hepatitis" composed of hospital staff with a hepatitis medical care coordinator. Kanzo. 62(6). 337–348. 2 indexed citations

2.

Kaneko‐Kawano, Takako, Fugo Takasu, Honda Naoki, et al.. (2012). Dynamic Regulation of Myosin Light Chain Phosphorylation by Rho-kinase. PLoS ONE. 7(6). e39269–e39269. 45 indexed citations

3.

Kimura, Takehiro, Aiko Okada, Taku Yatabe, et al.. (2010). RECK Is Up-Regulated and Involved in Chondrocyte Cloning in Human Osteoarthritic Cartilage. American Journal Of Pathology. 176(6). 2858–2867. 13 indexed citations

4.

Okada, Aiko & Yasunori Okada. (2009). [Progress of research in osteoarthritis. Metalloproteinases in osteoarthritis].. PubMed. 19(11). 1593–601. 19 indexed citations

5.

Takizawa, Masayuki, Taku Yatabe, Aiko Okada, et al.. (2008). Calcium pentosan polysulfate directly inhibits enzymatic activity of ADAMTS4 (aggrecanase‐1) in osteoarthritic chondrocytes. FEBS Letters. 582(19). 2945–2949. 24 indexed citations

6.

Yatabe, Taku, Satsuki Mochizuki, Miyuki Chijiiwa, et al.. (2008). Hyaluronan inhibits expression of ADAMTS4 (aggrecanase-1) in human osteoarthritic chondrocytes. Annals of the Rheumatic Diseases. 68(6). 1051–1058. 133 indexed citations

7.

Okada, Aiko, Satsuki Mochizuki, Taku Yatabe, et al.. (2008). ADAM‐12 (meltrin α) is involved in chondrocyte proliferation via cleavage of insulin‐like growth factor binding protein 5 in osteoarthritic cartilage. Arthritis & Rheumatism. 58(3). 778–789. 53 indexed citations

8.

Shiomi, Takayuki, Aiko Okada, Takehiro Kimura, et al.. (2007). Expression of ADAMTS4 (aggrecanase‐1) in human osteoarthritic cartilage. Pathology International. 57(11). 703–711. 97 indexed citations

9.

Kodama, Takahide, Eiji Ikeda, Aiko Okada, et al.. (2004). ADAM12 Is Selectively Overexpressed in Human Glioblastomas and Is Associated with Glioblastoma Cell Proliferation and Shedding of Heparin-Binding Epidermal Growth Factor. American Journal Of Pathology. 165(5). 1743–1753. 125 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact